TCG Crossover Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
39
2025
Q1
Sell
-550,000
Closed -$8.71M 38
2024
Q4
$8.71M Sell
550,000
-329,344
-37% -$5.21M 0.85% 31
2024
Q3
$51.1M Hold
879,344
4.33% 8
2024
Q2
$40.2M Hold
879,344
4.19% 9
2024
Q1
$58.2M Buy
+879,344
New +$58.2M 4.6% 8